Pay in 4 interest-free payments of $7.50 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
CX-5461 demonstrates a favorable preclinical profile
Smiles: C/C(=N\OCC1C=CC(C2CCCCC2)=C(C=1)C(F)(F)F)/C1C=C(CC)C(CN2CC(C2)C(O)=O)=CC=1
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells
Palbociclib (PD 0332991) exhibits significant antitumor efficacy against multiple human tumor xenograft models
BMS-790052 2HCl - CAS# 1009119-65-6 60236 CX-5461 demonstrates a favorable preclinicalBMS 790052, CAS No. 1009119 65 6, is a highly selective inhibitor of HCV NS5A with EC50 of 9 50 pM, for a broad range of HCV replicon genotypes and the JFH 1 genotype 2a infectious virus in cell culture. IC50 Value: 9 50 pM Target: HCV NS5A BMS 790052 has broad genotype coverage and exhibits picomolar. Product information CAS Number: 1009119 65 6 Molecular Weight: 811. 80 Formula: C40H52Cl2N8O6 Chemical Name: methyl N [(2S) 1 [(2S) 2 [5 [4 [4 [2 [(2S)
US$ 173.00
US$ 55.16
US$ 89.98
US$ 45.99
US$ 10.32
US$ 11.90
US$ 598.38
US$ 15.84